Colorado Springs teacher selected for VFW Top Award
Christie Wingo, a middle school science, technology, engineering, and math teacher at Colorado Springs Christian School, was selected to receive the award at the middle-school level. Each year, the Veterans of Foreign Wars (VFW) selects elementary, middle, and high school teachers to participate in the Smart/Maher VFW National Citizenship Education Teacher program.
The program was launched by the VFW to recognize classroom teachers for their 'outstanding' commitment to teaching Americanism and patriotism to their students.
Wingo was sponsored by VFW Post 7829 in Monument. According to the VFW, Wingo 'was chosen for her continued efforts to prepare responsible citizens while encouraging a strong passion for STEM and fostering an atmosphere that values hard work, collaboration, and bettering their community.'
As a member of the Space Foundation's International Teacher Liaisons Group, Wingo uses space-related educational programs and practical resources in the classroom. Wingo also works to bolster education on cybersecurity, biomedical engineering, machine learning, and robotics.
Wingo is also working on bringing hands-on projects to the school to further inspire her students.
'The VFW is proud to recognize outstanding educators like Christie who inspire civic responsibility and patriotism in our youth, ensuring the pillars of our democracy are not forgotten,' said VFW National Commander Al Lipphardt. 'Beyond academics, she inspires critical thinking, a deep respect for democracy, and helps foster curiosity. Her influence extends far beyond the classroom, helping to cultivate a generation that values integrity, civic duty, and the power of informed decision-making — essential qualities for those who will guide our nation forward.'
Two other teachers from Illinois and New Jersey were also recognized. Wingo and the other two national recipients will be presented with a $1,000 award for professional development and $1,000 for their school during the 126th VFW National Convention in Ohio on Aug. 9-13.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
19-07-2025
- Business Insider
FDA investigating risk of acute liver failure with Sarepta gene therapies
As of July 18, 2025, the Food and Drug Administration said it has received three reports of fatal acute liver failure following treatment of patients with Sarepta (SRPT) AAVrh74 gene therapies that appear to have been caused by the gene therapy products as a result of acute liver failure. The agency added, 'FDA is investigating the risk of acute liver failure with serious outcomes, including those such as hospitalization and death, following gene therapies using Sarepta's AAVrh74 gene therapy products, and the need for further regulatory action(s).' Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Business Insider
09-07-2025
- Business Insider
AptarGroup debuts dual-active technology to control moisture, oxygen
AptarGroup (ATR) announced it has developed a dual-active material science technology engineered to simultaneously control moisture and oxygen. The company stated this technology is designed to provide a singular solution to address degradation drivers for pharmaceutical drugs, including oral solid dose GLP-1 medications, and medical devices. The new solution marks a breakthrough in the pharmaceutical industry and extends Aptar's 3-Phase Activ-Polymer technology into new use cases. Don't Miss TipRanks' Half-Year Sale Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Business Insider
02-07-2025
- Business Insider
Alpha Cognition shares preclinical data for TBI drug ALPHA-1062
Alpha Cognition (ACOG) announced preclinical data supporting the continued development of ALPHA-1062 for the treatment of mild traumatic brain injury, or mTBI. The study, supported by the U.S. Department of Defense and conducted with VA investigators, demonstrated that ALPHA-1062 administration following blast-induced mTBI resulted in a notable reduction in indices of TBI-associated neuropathology, including toxic forms of brain protein Tau. These changes suggest a potential role for ALPHA-1062 in treating TBI and possibly reducing the risk of later Alzheimer's disease. Next steps include formulation for sublingual administration and a bridging pharmacokinetic study. Don't Miss TipRanks' Half-Year Sale Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
